Chen Wang

ORCID: 0000-0003-2638-3081
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Cancer Genomics and Diagnostics
  • Cancer-related molecular mechanisms research
  • Bioinformatics and Genomic Networks
  • RNA modifications and cancer
  • Gene expression and cancer classification
  • Epigenetics and DNA Methylation
  • Cancer-related gene regulation
  • Peptidase Inhibition and Analysis
  • PARP inhibition in cancer therapy
  • Ferroptosis and cancer prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Genetic factors in colorectal cancer
  • RNA Research and Splicing
  • Gene Regulatory Network Analysis
  • CRISPR and Genetic Engineering
  • Immune cells in cancer
  • MicroRNA in disease regulation
  • Molecular Biology Techniques and Applications
  • Virus-based gene therapy research
  • BRCA gene mutations in cancer
  • demographic modeling and climate adaptation
  • Cancer, Lipids, and Metabolism
  • Biomedical Text Mining and Ontologies
  • Genomics and Rare Diseases

WinnMed
2013-2025

Amgen (United States)
2025

Sun Yat-sen University
2018-2025

Shanghai Jiao Tong University
2022-2025

The First Affiliated Hospital, Sun Yat-sen University
2023-2025

Shanxi Academy of Medical Sciences
2025

Shanxi Medical University
2017-2025

Changzhi Medical College
2025

Mayo Clinic in Florida
2015-2024

Mayo Clinic
2013-2024

Aneuploidy, whole chromosome or arm imbalance, is a near-universal characteristic of human cancers. In 10,522 cancer genomes from The Cancer Genome Atlas, aneuploidy was correlated with TP53 mutation, somatic mutation rate, and expression proliferation genes. Aneuploidy anti-correlated immune signaling genes, due to decreased leukocyte infiltrates in high-aneuploidy samples. Chromosome arm-level alterations show cancer-specific patterns, including loss 3p squamous We applied genome...

10.1016/j.ccell.2018.03.007 article EN cc-by-nc-nd Cancer Cell 2018-04-01

<h2>Summary</h2> DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic response. We systematically analyzed somatic alterations to provide a comprehensive view of DDR deficiency across 33 types. Mutations with accompanying loss heterozygosity were observed in over 1/3 genes, including <i>TP53</i> <i>BRCA1/2</i>. Other prevalent included epigenetic silencing the direct genes <i>EXO5</i>, <i>MGMT</i>, <i>ALKBH3</i> ∼20% samples. Homologous recombination (HRD) was...

10.1016/j.celrep.2018.03.076 article EN cc-by-nc-nd Cell Reports 2018-04-01

Highlights•871 predisposition variants/CNVs discovered in 8% of 10,389 cases 33 cancers•Pan-cancer approach identified shared variants and genes across cancers•33 affecting activating domains oncogenes showed high expression•47 VUSs prioritized using cancer enrichment, LOH, expression other evidenceSummaryWe conducted the largest investigation to date, discovering 853 pathogenic or likely from types. Twenty-one single cross-cancer associations, including novel associations SDHA melanoma...

10.1016/j.cell.2018.03.039 article EN cc-by-nc-nd Cell 2018-04-01
Ashton C. Berger Anil Korkut Rupa S. Kanchi Apurva M. Hegde Walter F. Lenoir and 95 more Wenbin Liu Yuexin Liu Huihui Fan Hui Shen Visweswaran Ravikumar Arvind Rao André Schultz Xubin Li Pavel Sumazin Cecilia Williams Pieter Mestdagh Preethi H. Gunaratne Christina Yau Reanne Bowlby A. Gordon Robertson Daniel Guimarães Tiezzi Chen Wang Andrew D. Cherniack Andrew K. Godwin Nicole M. Kuderer Janet S. Rader Rosemary E. Zuna Anil K. Sood Alexander J. Lazar Akinyemi I. Ojesina Clement Adebamowo Sally N. Adebamowo Keith Baggerly Ting-Wen Chen Hua‐Sheng Chiu Steve Lefever Liang Liu Karen L. MacKenzie Sandra Oršulić Jason Roszik Carl Simon Shelley Qianqian Song Christopher P. Vellano Nicolas Wentzensen John N. Weinstein Gordon B. Mills Douglas A. Levine Rehan Akbani Rory Johnson John A. Demchok Ina Felau Melpomeni Kasapi Martin L. Ferguson Carolyn M. Hutter Heidi J. Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C. Zenklusen Jiashan Zhang Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Juok Cho Timothy Defreitas Scott Frazer Nils Gehlenborg Gad Getz David I. Heiman Seungchan Kim Michael S. Lawrence Pei Lin Thomas J. Giordano Michael S. Noble Gordon Saksena Doug Voet Hailei Zhang Brady Bernard Nyasha Chambwe Varsha Dhankani Theo Knijnenburg Roger Kramer Kalle Leinonen Yuexin Liu Michael Miller Sheila M. Reynolds Ilya Shmulevich Vésteinn Thórsson Wei Zhang Rehan Akbani Bradley M. Broom Apurva M. Hegde Zhenlin Ju Rupa S. Kanchi Anil Korkut

We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique features, clinically significant subtypes, potential therapeutic targets. found 61 somatic copy-number alterations (SCNAs) 46 significantly mutated genes (SMGs). Eleven SCNAs 11 SMGs had not been identified in previous TCGA studies the individual tumor types. functionally estrogen receptor-regulated long non-coding RNAs (lncRNAs)...

10.1016/j.ccell.2018.03.014 article EN cc-by-nc-nd Cancer Cell 2018-04-01

Abstract Previous genome-wide association studies (GWAS), conducted by our group and others, have identified loci that harbor risk variants for neurodegenerative diseases, including Alzheimer's disease (AD). Human are enriched polymorphisms affect gene expression, some known to associate with expression changes in the brain. Postulating many confer via transcriptional regulatory mechanisms, we analyzed levels brain tissue of subjects AD related diseases. Herein, describe collective datasets...

10.1038/sdata.2016.89 article EN cc-by Scientific Data 2016-10-10

Molecular classification of high-grade serous ovarian cancer (HGSOC) using transcriptional profiling has proven to be complex and difficult validate across studies. We determined gene expression profiles 174 well-annotated HGSOCs demonstrate prognostic significance the prespecified TCGA Network signatures. Furthermore, we confirm presence four HGSOC subtypes a de novo classification. Survival differed statistically significantly between (log rank, P = .006) was best for immunoreactive-like...

10.1093/jnci/dju249 article EN JNCI Journal of the National Cancer Institute 2014-09-30

Summary Downregulation of the transcription factor AtMYB103 using transgenic technology results in early tapetal degeneration and pollen aberration during anther development Arabidopsis thaliana . This paper describes functional analysis gene three knock‐out mutants. Two male sterile mutants, ms188‐1 ms188‐2 , were generated by ethyl‐methane sulfonate (EMS) mutagenesis. A map‐based cloning approach was used, ms188 mapped to a 95.8‐kb region on chromosome 5 containing an factor. Sequence...

10.1111/j.1365-313x.2007.03254.x article EN The Plant Journal 2007-08-28
Ellen L. Goode Matthew S. Block Kimberly R. Kalli Robert A. Vierkant Wenqian Chen and 94 more Zachary C. Fogarty Aleksandra Gentry‐Maharaj Aleksandra Tołoczko Alexander Hein Aliecia L. Bouligny Allan Jensen Ana Osório Andreas D. Hartkopf Andy Ryan Anita Chudecka-Głaz Anthony M. Magliocco Arndt Hartmann Audrey Jung Bo Gao Brenda Y. Hernandez Brooke L. Fridley Bryan M. McCauley Catherine J. Kennedy Chen Wang Chloe Karpinskyj Christiani Bisinoto de Sousa Daniel Guimarães Tiezzi David L. Wachter Esther Herpel Florin‐Andrei Taran Francesmary Modugno Gregg Nelson Jan Lubiński Janusz Menkiszak Jennifer Alsop Jenny Lester Jesús García-Donás Jill Nation Jillian A. Hung José Palacios Joseph H. Rothstein Joseph L. Kelley Jurandyr Moreira de Andrade Luis A. Díaz‐Robles Maria P. Intermaggio Martin Widschwendter Matthias W. Beckmann Matthias Ruebner Mercedes Jimenez‐Liñan Naveena Singh Oleg Oszurek Paul R. Harnett Peter Rambau Hans‐Peter Sinn Philipp Wagner Prafull Ghatage Raghwa Sharma Robert P. Edwards Roberta B. Ness Sandra Oršulić Sara Y. Brucker Sharon E. Johnatty Teri A. Longacre Ursula Eilber Valerie McGuire Weiva Sieh Yanina Natanzon Zheng Li Alice S. Whittemore Anna deFazio Annette Staebler Beth Y. Karlan C. Blake Gilks David D.L. Bowtell Estrid Høgdall Francisco José Cândido dos Reis Helen Steed Ian Campbell Jacek Gronwald Javier Benı́tez Jennifer M. Koziak Jenny Chang‐Claude Kirsten B. Moysich Linda E. Kelemen Linda S. Cook Marc T. Goodman María J. García Peter A. Fasching Stefan Kommoss Suha Deen Susanne K. Kjær Usha Menon James D. Brenton Paul D.P. Pharoah Georgia Chenevix‐Trench David G. Huntsman Stacey J. Winham Martin Köbel Susan J. Ramus

Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns TILs by histotype and relation to other clinical factors.

10.1001/jamaoncol.2017.3290 article EN JAMA Oncology 2017-10-19

Highlights•SCCs show chromosome or methylation alterations affecting multiple related genes•These regulate squamous stemness, differentiation, growth, survival, and inflammation•Copy-quiet SCCs have hypermethylated (FANCF, TET1) mutated (CASP8, MAPK-RAS) genes•Potential targets include ΔNp63, WEE1, IAPs, PI3K-mTOR/MAPK, immune responsesSummaryThis integrated, multiplatform PanCancer Atlas study co-mapped identified distinguishing molecular features of cell carcinomas (SCCs) from five sites...

10.1016/j.celrep.2018.03.063 article EN cc-by-nc-nd Cell Reports 2018-04-01
Davina J. Hensman Moss Antonio F. Pardiñas Douglas R. Langbehn Kitty Lo Blair R. Leavitt and 95 more Raymund A.C. Roos Alexandra Dürr Simon Mead Peter Holmans L. Jones Sarah J. Tabrizi A. Coleman R. Dar Santos Joji Decolongon Aaron Sturrock Éric Bardinet C Jauff Ret Damián Justo Stéphane Lehéricy Cécilia Marelli K Nigaud Romain Valabrègue S. van den Bogaard Eve M. Dumas Jeroen van der Grond EP t'Hart Caroline K. Jurgens M-N Witjes-Ane Natalie Arran Jenny Callaghan Cheryl Stopford Chris Frost Rebecca Jones Nicola Z. Hobbs Nayana Lahiri Roger J. Ordidge Gail Owen Tracey Pepple Joy Read M Say Edward J. Wild Aakta Patel Nick C. Fox Clare R. Gibbard Ian B. Malone Helen Crawford D. Whitehead Stephen Keenan David M. Cash C. Berna N Bechtel Stefan Bohlen Alana Man P Kraus Eric Axelson Chen Wang T Acharya Sang Lee W Monaco Colin Campbell Sarah Queller Kathryn B. Whitlock Colin Campbell Melissa Campbell E Frajman C Milchman Alison O’Regan Izelle Labuschagne Julie C. Stout G. Bernhard Landwehrmeyer David Craufurd Rachael I. Scahill S. Hicks Christopher Kennard Hans J. Johnson Allan J. Tobin H. Diana Rosas Ralf Reilmann Beth Borowsky C Pourchot Sophie C. Andrews Anne‐Catherine Bachoud‐Lévi Anna Rita Bentivoglio Ida Biunno Raphael M. Bonelli Jean‐Marc Burgunder Stephen B. Dunnett Joaquim J. Ferreira Olivia Handley Arvid Heiberg Torsten Illmann G. Bernhard Landwehrmeyer Jamie Levey María A. Ramos-Arroyo Jørgen E. Nielsen Susana Pro Koivisto Markku Päivärinta R. A. C. Roos Ana Rojo Sebastián Sarah J. Tabrizi

10.1016/s1474-4422(17)30161-8 article EN The Lancet Neurology 2017-06-20

Immune checkpoint blockade (ICB) has revolutionized cancer therapeutics. Desmoplastic malignancies, such as cholangiocarcinoma (CCA), have an abundant tumor immune microenvironment (TIME). However, to date, ICB monotherapy in malignancies been ineffective. Herein, we identify tumor-associated macrophages (TAMs) the primary source of programmed death–ligand 1 (PD-L1) human and murine CCA. In a model CCA, recruited PD-L1+ TAMs facilitated CCA progression. TAM failed decrease progression due...

10.1172/jci137110 article EN Journal of Clinical Investigation 2020-07-14

Abstract DNA polymorphism is the basis to develop molecular markers that are widely used in genetic mapping today. A genome-wide rice (Oryza sativa) database has been constructed this work using genomes of Nipponbare, a cultivar japonica, and 93-11, indica. This contains 1,703,176 single nucleotide polymorphisms (SNPs) 479,406 Insertion/Deletions (InDels), approximately one SNP every 268 bp InDel 953 genome. Both SNPs InDels were experimentally validated. Of 109 randomly selected SNPs, 107...

10.1104/pp.103.038463 article EN PLANT PHYSIOLOGY 2004-07-01

During mitosis, chromosomes are highly condensed and transcription is silenced globally. One explanation for transcriptional repression the reduced accessibility of factors. To directly test this hypothesis to investigate dynamics mitotic chromatin, we evaluate exchange kinetics several RNA polymerase I factors nucleosome components on chromatin in living cells. We demonstrate that these rapidly off ribosomal DNA clusters varies at different phases mitosis. In addition, component H1c-GFP...

10.1083/jcb.200407182 article EN The Journal of Cell Biology 2004-12-28

miR-182 is one of the most significantly up-regulated miRNAs in hepatocellular carcinoma (HCC). Metastasis suppressor 1 (MTSS1), target gene miR-182, plays an important role metastasis cancers. However, it remains unclear what does function and mechanism MTSS1play HCC. expression was tested 86 cases paired HCC normal tissues by real-time PCR relationships between clinicopathological parameters were analyzed. The MTSS1 evaluated immunohistochemistry western blot above its correlation with...

10.1186/1471-2407-12-227 article EN cc-by BMC Cancer 2012-06-08

We evaluated homologous recombination deficient (HRD) phenotypes in epithelial ovarian cancer (EOC) considering BRCA1, BRCA2 and RAD51C a large well-annotated patient set. EOC patients for germline deleterious mutations (n = 899), somatic 279) epigenetic alterations 482) these genes using NGS genome-wide methylation arrays. Deleterious were identified 32 (3.6%) 28 (3.1%) 26 (2.9%) RAD51C. Ten somatically sequenced had alterations, six (2.1%) BRCA1 four (1.4%) BRCA2. Fifty two (10.8%)...

10.1038/srep04026 article EN cc-by-nc-nd Scientific Reports 2014-02-07

Ulcerative colitis (UC) is a major form of chronic inflammation that can frequently progress to colon cancer. Several studies have demonstrated massive infiltration neutrophils and macrophages into the lamina propria submucosa in progression UC-associated carcinogenesis. Macrophages contribute development colitis-associated cancer (CAC). However, role not well understood. To better understand involvement tumor-associated (TANs) regulation CAC, we used mouse CAC model produced by...

10.1371/journal.pone.0051848 article EN cc-by PLoS ONE 2012-12-18

Purpose: Recent progress in understanding the molecular biology of epithelial ovarian cancer has not yet translated into individualized treatment for these women or improvements their disease outcome. Gene expression been utilized to identify distinct subtypes, but there have no reports investigating whether subtyping is predictive response bevacizumab cancer.Experimental Design: DASL gene arrays were performed on FFPE tissue from patients enrolled ICON7 trial. Patients stratified four TCGA...

10.1158/1078-0432.ccr-16-2196 article EN Clinical Cancer Research 2017-02-04
Coming Soon ...